Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Nanoscope Therapeutics
organization5 mentionslast seen Nov 5, 2026
Biotechnology company developing optogenetic gene therapies for retinal degeneration.
Relationships 10
- Nanoscope TherapeuticsemploysSamarendra Mohanty99% confidence5 sources
- Nanoscope TherapeuticsdevelopsMOGENRY99% confidence5 sources
- Nanoscope TherapeuticsemploysSulagna Bhattacharya99% confidence3 sources
- Nanoscope Therapeuticsdevelopsmulti-characteristic opsin99% confidence2 sources
- Nanoscope TherapeuticsemploysDamon Daulerio98% confidence1 source
- Nanoscope TherapeuticsemploysTroy Short98% confidence1 source
- Nanoscope TherapeuticsemploysSam Barone97% confidence1 source
- Nanoscope TherapeuticsemploysRamesh Arjunji97% confidence1 source
- Nanoscope TherapeuticsemploysPaul Hallen97% confidence1 source
- Nanoscope TherapeuticsemploysAnanta Ayagari90% confidence1 source
Relationship
Nanoscope TherapeuticsdevelopsMOGENRY
99% confidence5 supporting mentions
Either name opens that entity’s relationships.
Sources 5
- newsPR NewswireNov 5, 2026Nanoscope Therapeutics Appoints Ophthalmology and Rare Disease Regulatory Leader Damon Daulerio as Executive Director of Regulatory Affairs
Mr. Daulerio will execute on Nanoscope's global regulatory strategy and participate in interactions with health authorities as the company advances toward the potential approval and launch of MOGENRY®
- newsPR NewswireOct 29, 2026Nanoscope Therapeutics to Participate in Advanced Therapies USA 2026 in Boston
Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies
- newsPR NewswireOct 14, 2026Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
developing and commercializing novel, disease-agnostic therapies
- newsPR NewswireOct 6, 2026Nanoscope Therapeutics to Participate in Eyecelerator 2026 and the American Academy of Ophthalmology 2026 Annual Meeting
Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies
- newsPR NewswireSep 29, 2026Nanoscope Therapeutics to Present at Meeting on the Mesa 2026
Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies